5 Essential Elements For Sulfoxaflor
All enrolled patients who acquired at the least 1 dose of zosuquidar or placebo during induction were monitored to the incidence of adverse situations (439 patients, 219 on zosuquidar and 210 on placebo). The most common adverse events had been relevant to the duration of extended and considerable myelosuppression as is predicted with induction che